Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela M. Zagalo
Institutions:
Bluepharma (Portugal),
University of Coimbra
Observed institutions:
Bluepharma (Portugal),
University of Coimbra
ORCID:
0000-0002-7592-561X
Observed ORCID:
0000-0002-7592-561X
OpenAlex ID:
A5069392325
Works
3
Awards
1
A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review
2022
·
Daniela M. Zagalo
, Branca M.A. Silva
, et al.
·
Journal of Drug Delivery Science and Technology
·
59
Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluation
2022
·
Daniela M. Zagalo
, João Sousa
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
51
Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug Products
2022
·
Daniela M. Zagalo
, Sérgio Simões
, et al.
·
Journal of Pharmaceutical Sciences
·
24
Show more works
View as search
Works count:
3
Citation count:
134
H-index:
3
I10-index:
3
Year
Topic
Type
